Medivation
Most Read
Pfizer buying Medivation in deal valued at about $14 billion
Pharmalot, Pharmalittle: Pfizer pays $14 billion for Medivation and its prostate cancer drug
Pharmalot, Pharmalittle: Medivation to start takeover talks with Sanofi and others
Pharmalot, Pharmalittle: France opens criminal probe into clinical trial
Pharmalot, Pharmalittle: Drug maker compliance reviews may have conflicts
Pharmalot, Pharmalittle: Odds of an early-stage biotech drug winning approval are slim
